Previous close | 18.94 |
Open | 18.67 |
Bid | 17.00 |
Ask | 22.00 |
Strike | 65.00 |
Expiry date | 2025-01-17 |
Day's range | 18.94 - 18.94 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Lower inflation means less top-line growth from price hikes, and sales volume is under pressure as consumers are more selective.
Investing.com -- As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than others as patients on these weight-loss drugs shift appetite in favor of more protein-based foods.
CPB's focus on innovation, portfolio reshaping and maintaining affordability positions it well for growth. Yet, cost inflation and Snacks unit hurdles remain.